Impact Biomedical Inc. (IBO) vs Seres Therapeutics, Inc. (MCRB)
- Impact Biomedical Inc. IBO 2.68 −15.19%
- Seres Therapeutics, Inc. MCRB 2.46 −2.77%
Impact Biomedical Inc. and Seres Therapeutics, Inc. are both Biotechnology companies. Impact Biomedical Inc. and Seres Therapeutics, Inc. are of similar size ($27.0M and $25.2M). Seres Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Impact Biomedical Inc. trades at 0.2×. Impact Biomedical Inc. has the higher net margin (2,254.3% vs −1,192.9%) and the higher return on invested capital (−22.8% vs −277.3%). Across the 15 metrics below, Impact Biomedical Inc. leads on 9 and Seres Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | IBO | MCRB | Biotechnology median |
|---|---|---|---|
| Gross margin | (1,111.43%) | 100.00% | 65.16% |
| Operating margin | (14,600.00%) | (4,462.77%) | 0.00% |
| Net margin | 2,254.29% | (1,192.94%) | 0.00% |
| Free cash flow margin | (1,451.43%) | (2,721.83%) | 0.00% |
| Return on equity | 24.01% | (66.57%) | (56.36%) |
| Return on assets | 4.41% | (18.31%) | (48.04%) |
| Return on invested capital | (22.81%) | (277.30%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack